Epidarex’s successful £47.5m ($79.5m) fundraise makes for a prime example of universities putting their money where their mouths are. Formerly known as Rock Spring Ventures, the fund is looking to bridge the funding gap in UK life sciences – with the aim of becoming a “local champion” for the sector.
The fund has attracted four UK universities as limited partners for the fund: King’s College London, Glasgow University, Edinburgh University, and Aberdeen University. While the fund will be looking to invest in UK life science startups in general, the four universities’ spin-outs will automatically be a higher priority target of investment by Epidarex, which is also supported by pharmaceutical firm Eli Lilly, the European Investment Fund, Scottish Enterprise, and Strathclyde Pension Fund.
To read the original article: Epidarex pulls the pieces together · Articles · Global University Venturing
